You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Muscarinic M1 Receptor

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC(NSCLC) Trial in Worldwide (AT13387, Crizotinib)

Completed
  • Non-small Cell Lung Cancer(NSCLC)
  • Scottsdale, Arizona
  • +64 more
Jan 17, 2018

Postoperative Pain Trial in New York (Ketamine, Placebo)

Completed
Has Results
  • Postoperative Pain
  • New York, New York
    NYU School of Medicine
May 19, 2017

Melanoma Trial in France (Nivolumab, hypofractionned radiotherapy)

Unknown status
  • Melanoma
  • Nivolumab
  • hypofractionned radiotherapy
  • Amiens, France
  • +13 more
Aug 22, 2017

B Cell Lymphoma Trial in Shenzhen (Fludarabine, Cyclophosphamide, CD19 CART)

Unknown status
  • B Cell Lymphoma
  • Shenzhen, Guangdong, China
    The Second People's Hospital of Shenzhen
May 16, 2017

SIRS and Bacterial Sepsis Discrimination by Biomarkers in ICU

Completed
  • SIRS
  • +3 more
    • Paris, France
      Groupe hospitalier Paris Saint Joseph
    Oct 15, 2017

    Schizophrenia Trial in Denver (Risperidone plus Placebo, Risperidone plus DMXB-A)

    Withdrawn
    • Schizophrenia
    • Risperidone plus Placebo
    • Risperidone plus DMXB-A
    • Denver, Colorado
      VA Eastern Colorado Health Care System, Denver, CO
    May 25, 2017

    Circulating Tumor Cells From Metastatic Breast Cancer Using

    Completed
    • Metastatic Breast Cancer
    • Blood collection
    • Phoenix, Arizona
    • +19 more
    Mar 7, 2017

    Poorly Differentiated Thyroid Gland Carcinoma, Recurrent Thyroid Gland Carcinoma, Stage I Thyroid Gland Follicular Carcinoma

    Completed
    Has Results
    • Poorly Differentiated Thyroid Gland Carcinoma
    • +15 more
    • Cabozantinib S-malate
    • Laboratory Biomarker Analysis
    • Washington, District of Columbia
    • +6 more
    Mar 7, 2018

    Pulmonary Disease, Chronic Obstructive Trial in Worldwide (UMEC DPI, Placebo DPI, ICS/LABA medication)

    Completed
    Has Results
    • Pulmonary Disease, Chronic Obstructive
    • UMEC DPI
    • +3 more
    • Kurim, Czechia
    • +28 more
    Jul 10, 2017

    Pulmonary Disease, Chronic Obstructive Trial in Worldwide (fluticasone furoate (FF, GW685698)/vilanterol (VI, GW642444) 100/25

    Completed
    Has Results
    • Pulmonary Disease, Chronic Obstructive
    • fluticasone furoate (FF, GW685698)/vilanterol (VI, GW642444) 100/25 mcg Novel Dry Powder Inhaler (NDPI)
    • Tiotropium
    • Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
    • +54 more
    Jan 18, 2018

    B-Cell Leukemia, B-Cell Lymphoma Trial in Shijiazhuang (Autologous CD19-targeting CAR T cells)

    Unknown status
    • B-Cell Leukemia
    • B-Cell Lymphoma
    • Autologous CD19-targeting CAR T cells
    • Shijiazhuang, Hebei, China
      No.2 Hospital of Hebei Medical University
    Apr 27, 2017

    Hearing Loss, Sudden Trial in New Hyde Park (anakinra)

    Terminated
    Has Results
    • Hearing Loss, Sudden
    • New Hyde Park, New York
      North Shore-LIJ Hearing and Speech Center
    Jan 31, 2017

    Hypertension, Resistant to Conventional Therapy Trial in Hannover (Hypoxia without dopamine, Hypoxia with dopamine, Hyperoxia

    Completed
    • Hypertension, Resistant to Conventional Therapy
    • Hypoxia without dopamine
    • +3 more
    • Hannover, LSX, Germany
      Hannover Medical School
    Jan 8, 2018

    Head Neck Cancer Trial in United States (IMC-A12 (cixutumumab), cetuximab (Erbitux ®))

    Completed
    Has Results
    • Head and Neck Cancer
    • IMC-A12 (cixutumumab)
    • cetuximab (Erbitux ®)
    • Orange, California
    • +13 more
    Mar 17, 2018

    Advanced Solid Tumor Trial in Ningbo (Anti-CTLA-4/PD-1 expressing MUC1-CAR-T)

    Unknown status
    • Advanced Solid Tumor
    • Anti-CTLA-4/PD-1 expressing MUC1-CAR-T
    • Ningbo, Zhejiang, China
      Ningbo No.5 Hospital (Ningbo Cancer Hospital)
    Jun 5, 2017

    Cancer of the Pharynx, Cancer of the Larynx, Cancer of the Neck Trial in New York (erlotinib + celecoxib)

    Completed
    Has Results
    • Cancer of the Pharynx
    • +4 more
    • erlotinib + celecoxib
    • New York, New York
      Mount Sinai School of Medicine
    Feb 24, 2017

    Advanced Solid Tumor Trial in Ningbo (CTLA-4/PD-1 antibodies expressing mesoCAR-T)

    Unknown status
    • Advanced Solid Tumor
    • CTLA-4/PD-1 antibodies expressing mesoCAR-T
    • Ningbo, Zhejiang, China
      Ningbo No.5 Hospital (Ningbo Cancer Hospital)
    Jun 7, 2017

    Sunitinib and Sorafenib on Fatigue, QoL, Depression in

    Completed
    • Renal Cell Cancer
    • +2 more
    • Questionnaires
    • Nijmegen, Netherlands
      University Medical Center Nijmegen st Radboud
    Nov 24, 2017

    Atherosclerosis, Myocardial Ischemia, Myocardial Infarction Trial (Vorapaxar, Placebo)

    Terminated
    Has Results
    • Atherosclerosis
    • +2 more
    • (no location specified)
    Aug 22, 2018

    Telangiectasias Trial in Copenhagen NV (Brimonidine, IPL+air-cooling)

    Completed
    • Telangiectasias
    • Copenhagen NV, Denmark
      Bispebjerg Hospital
    Jan 3, 2018

    EGFR Mutation Using cfDNAs and Circulating Tumor Cells in NSCLC

    Unknown status
    • Lung Cancer
      • Taipei city, Taiwan
        National Taiwan University Hospital
      Dec 12, 2016

      Prostate Cancer Trial in Moscow, Saint Petersburg (Mobilan (M-VM3), Placebo)

      Completed
      • Prostate Cancer
      • Mobilan (M-VM3)
      • Placebo
      • Moscow, Russian Federation
      • +5 more
      Sep 19, 2017

      Cholangiocarcinomas Trial in Germany (Cisplatin, Gemcitabine, Panitumumab, Cisplatin, Gemcitabine)

      Completed
      • Cholangiocarcinomas
      • Cisplatin, Gemcitabine, Panitumumab
      • Cisplatin, Gemcitabine
      • Esslingen, Baden-Wuerttemberg, Germany
      • +15 more
      Oct 11, 2017

      Pulmonary Disease, Chronic Obstructive Trial in Worldwide (GSK573719/GW642444 125/25, GSK573719/GW642444 62.5/25, GSK573719 125)

      Completed
      Has Results
      • Pulmonary Disease, Chronic Obstructive
      • GSK573719/GW642444 125/25
      • +5 more
      • Jasper, Alabama
      • +52 more
      Jan 18, 2018

      Ovarian Cancer Trial in Minneapolis (Fulvestrant)

      Completed
      Has Results
      • Ovarian Cancer
      • Minneapolis, Minnesota
        Masonic Cancer Center at University of Minnesota
      Dec 3, 2017